Birth Defects

Fuatilia
Concerned pregnant woman examines valproate prescription amid world map showing persistent high global use in pregnancy risk zones, per international study.
Picha iliyoundwa na AI

Study warns that global use of valproate in pregnancy risk zones remains high

Imeripotiwa na AI Picha iliyoundwa na AI Imethibitishwa ukweli

An international study across 73 countries finds that access to antiseizure medicines is improving, especially in low- and middle-income nations, but warns that valproate — a World Health Organization-listed essential medicine linked to serious birth defects when used in pregnancy — remains widely used. Researchers led by Aston University report uneven progress in safe prescribing between 2012 and 2022 and call for stronger safeguards for women of childbearing age.

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.
Kataa